Related Experiment Video
Updated: Apr 27, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Cationic PAMAM dendrimers disrupt key platelet functions.
Clinton F Jones1, Robert A Campbell, Zechariah Franks
1Department of Pharmaceutics and Pharmaceutical Chemistry, Health Sciences, University of Utah , Salt Lake City, Utah 84112-5820, United States.
Poly(amidoamine) dendrimers (PAMAM) can activate platelets, altering their shape and function. This research investigates PAMAM dendrimer interactions with blood components to understand nanoparticle toxicity mechanisms.
Area of Science:
- Biomedical Nanotechnology
- Nanotoxicology
- Hematology
Background:
- Poly(amidoamine) dendrimers (PAMAM) are versatile nanoparticles with potential biomedical applications.
- Previous studies indicated lethal coagulopathy in mice following intravenous administration of amine-terminated PAMAM dendrimers.
Purpose of the Study:
- To elucidate the in vitro mechanisms underlying PAMAM-induced coagulopathy.
- To assess the effects of cationic G7 PAMAM dendrimers on platelet function.
Main Methods:
- In vitro assessment of platelet morphology and function.
- Evaluation of platelet aggregation, adherence, and thrombin generation in the presence of PAMAM dendrimers.
Main Results:
- Cationic G7 PAMAM dendrimers induced significant alterations in platelet morphology and activation.
- Platelet aggregation and adherence to surfaces were increased upon dendrimer exposure.
- Surprisingly, dendrimer exposure attenuated platelet-dependent thrombin generation.
Conclusions:
- PAMAM dendrimers exert complex effects on platelet function, impacting morphology, aggregation, and thrombin generation.
- These findings highlight the necessity for further research into PAMAM-specific and general nanoparticle toxicity in blood components.
More Related Videos
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...